Literature DB >> 3663446

The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.

H Chrystyn1, B A Mulley, M D Peake.   

Abstract

1. The accuracy of a computer based pharmacokinetic prediction method based on Bayesian analysis has been evaluated for an oral show release form of theophylline. 2. In 83 patients from seven centres 24 h serum theophylline concentration-time profiles were measured under a variety of circumstances. 3. Revised predictions of 24 h serum theophylline concentration profiles were generated by Bayesian analysis using single serum drug concentrations taken before, during and after the study days in different subgroups of those patients. Comparing the predicted and measured profiles the mean prediction error (bias) was 0.05 mg l-1 for peak concentrations and 0.04 mg l-1 for trough concentrations during once daily dosing. The corresponding root mean squared prediction errors (precision) were 2.59 and 1.17 mg l-1, respectively. 4. This accuracy is considered more than adequate for clinical purposes. 5. The technique can be used with a variety of other drugs and can form a valuable part of a routine therapeutic drug monitoring service.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663446      PMCID: PMC1386250          DOI: 10.1111/j.1365-2125.1987.tb03173.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.

Authors:  H Chrystyn; D H Morgan
Journal:  J Clin Hosp Pharm       Date:  1986-12

2.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

3.  Single-dose slow-release aminophylline at night prevents nocturnal asthma.

Authors:  P J Barnes; A P Greening; L Neville; J Timmers; G W Poole
Journal:  Lancet       Date:  1982-02-06       Impact factor: 79.321

4.  Comparison of three methods for estimating theophylline pharmacokinetics.

Authors:  R W Coleman; R L Hedberg
Journal:  Clin Pharm       Date:  1983 Mar-Apr

5.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

Authors:  W J Jusko; M J Gardner; A Mangione; J J Schentag; J R Koup; J W Vance
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

6.  Current concepts. Slow-release theophylline rationale and basis for product selection.

Authors:  M Weinberger; L Hendeles
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

7.  Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing.

Authors:  B Whiting; A W Kelman; S M Bryson; F H Derkx; A H Thomson; G H Fotheringham; S E Joel
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

8.  Some suggestions for measuring predictive performance.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

9.  The pharmacokinetics of uniphyllin in nocturnal asthma.

Authors:  I D Johnston; R Ayesh; E Alton; E G Essex; G M Cochrane; M R Hetzel
Journal:  Br J Dis Chest       Date:  1986-07

10.  Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study.

Authors:  G Hambleton; M Weinberger; J Taylor; M Cavanaugh; E Ginchansky; S Godfrey; M Tooley; T Bell; S Greenberg
Journal:  Lancet       Date:  1977-02-19       Impact factor: 79.321

View more
  5 in total

Review 1.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

2.  Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.

Authors:  H Chrystyn; J W Ellis; B A Mulley; M D Peake
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

Review 3.  An updated comparison of drug dosing methods. Part II: Theophylline.

Authors:  S M Erdman; K A Rodvold; R D Pryka
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

4.  Dose response relation to oral theophylline in severe chronic obstructive airways disease.

Authors:  H Chrystyn; B A Mulley; M D Peake
Journal:  BMJ       Date:  1988-12-10

5.  Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.

Authors:  Graham Devereux; Seonaidh Cotton; Peter Barnes; Andrew Briggs; Graham Burns; Rekha Chaudhuri; Henry Chrystyn; Lisa Davies; Anthony De Soyza; Shona Fielding; Simon Gompertz; John Haughney; Amanda J Lee; Kirsty McCormack; Gladys McPherson; Alyn Morice; John Norrie; Anita Sullivan; Andrew Wilson; David Price
Journal:  Trials       Date:  2015-06-10       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.